C34 PEG 4 CholAlternative Names: C34 polyethylene glycol 4 cholesterol; HIVP 3; Peptivir-H
Latest Information Update: 17 Feb 2015
At a glance
- Originator PeptiPharma
- Developer Imperial College of Science, Technology and Medicine
- Class Antivirals; Lipids; Polyethylene glycols
- Mechanism of Action HIV fusion inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Phase I HIV infections
Most Recent Events
- 15 Feb 2015 Phase-I clinical trials in HIV infections in United Kingdom (SC)